The impact of PBRM1 expression as a prognostic and predictive marker in metastatic renal cell carcinoma

Journal of Urology

Volumn 194, Issue 4, 2015, Pages 1112-1119

  Kim, Ji Yeon ^a   Lee, Se Hoon ^a   Moon, Kyung Chul ^a   Kwak, Cheol ^a   Kim, Hyeon Hoe ^a   Keam, Bhumsuk ^a   Kim, Tae Min ^a   Heo, Dae Seog ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

biological markers; carcinoma; human; kidney; mTOR protein; PBRM1 protein; renal cell

Indexed keywords

BIOLOGICAL MARKER; EVEROLIMUS; PBRM1 PROTEIN; SUNITINIB; UNCLASSIFIED DRUG; NUCLEAR PROTEIN; PBRM1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TISSUE MICROARRAY; TREATMENT OUTCOME; BIOSYNTHESIS; DISEASE FREE SURVIVAL; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SECONDARY; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84941600721     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.04.114     Document Type: Article

References (14)

1. N. Howlader, A.M. Noone, M. Krapcho, and et al. SEER Cancer Statistics Review, 1975-2011 2014 National Cancer Institute Bethesda
2. H.T. Cohen, and F.J. McGovern Renal-cell carcinoma N Engl J Med 353 2005 2477
3. P.H. Maxwell, M.S. Wiesener, G.W. Chang, and et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271
4. M.E. Cockman, N. Masson, D.R. Mole, and et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J Biol Chem 275 2000 25733
5. I. Varela, P. Tarpey, K. Raine, and et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539
6. Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma Nature 499 2013 43
7. P. Kapur, S. Pena-Llopis, A. Christie, and et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation Lancet Oncol 14 2013 159
8. R. Pawlowski, S.M. Muhl, T. Sulser, and et al. Loss of PBRM1 expression is associated with renal cell carcinoma progression Int J Cancer 132 2013 E11
9. W.H. da Costa, M. Rezende, F.C. Carneiro, and et al. Polybromo-1 (PBRM1), a SWI/SNF complex subunit is a prognostic marker in clear cell renal cell carcinoma BJU Int 113 2014 E157
10. D.Y. Heng, W. Xie, M.M. Regan, and et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study J Clin Oncol 27 2009 5794
11. R.J. Motzer, T.E. Hutson, P. Tomczak, and et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma N Engl J Med 356 2007 115
12. R.J. Motzer, B. Escudier, S. Oudard, and et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial Lancet 372 2008 449
13. G. Guo, Y. Gui, S. Gao, and et al. Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma Nat Genet 44 2012 17
14. R.W. Joseph, P. Kapur, D.J. Serie, and et al. Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma Cancer 120 2014 1059